Choline alphoscerate, 250 mg/ml 4 ml 5 pcs.

Cholinomimetic. It is a precursor of acetylcholine.

It mainly affects cholinergic receptors in CNS. Glycerophosphate, which is formed during the breakdown of choline alphoscerate, is a precursor of phospholipids (phosphatidylcholine) of the neuronal membrane.

Facilitates nerve impulse transmission in cholinergic neurons, improves neuronal membrane plasticity and receptor function.

Indications

Active ingredient

Composition

How to take, the dosage

Intravenously (dropwise) or intramuscularly (slowly) at a dose of 1000 mg/day.

In intravenous administration the contents of one ampoule (4 ml) are diluted in 50 ml of 0.9% sodium chloride solution, infusion rate 60-80 drops per minute. The duration of treatment is usually 10 days. If necessary, treatment may be continued as prescribed by the physician, depending on the clinical picture and characteristics of the course of the disease, age and tolerance of the drug.

After the patient’s condition has stabilized, it is possible to continue treatment with oral dosage forms of the drug.

The doses may be increased at the discretion of the physician.

Interaction

Special Instructions

Nausea may be a consequence of dopaminergic activation.
Efficacy and safety in children under 18 years of age have not been established.

Contraindications

Side effects

Overdose

Pregnancy use

Similarities